Alessandra Soriani

Pubblicazioni

Titolo Pubblicato in Anno
Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells ONCOIMMUNOLOGY 2016
Targeting NKG2D and NKp30 ligands shedding to improve NK cell–based immunotherapy CRITICAL REVIEWS IN IMMUNOLOGY 2016
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma BIOMED RESEARCH INTERNATIONAL 2015
Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells. ONCOSCIENCE 2015
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma ONCOTARGET 2015
The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress CELL DEATH AND DIFFERENTIATION 2015
The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro JOURNAL OF IMMUNOTHERAPY 2015
Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells. ONCOTARGET 2015
New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer JOURNAL OF MEDICINAL CHEMISTRY 2015
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation BMC CANCER 2015
Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells JOURNAL OF IMMUNOLOGY 2015

ERC

  • LS3_2
  • LS6_1
  • LS6_3

Interessi di ricerca

My research activities have been mainly conducted in the field of natural innate immunity and tumor immunology, with a specific interest in NK cell phenotype, activation and function. In particular, the main interest of my research activity was to study the interplay between NK cells and tumor cells to dissect the molecular pathways that regulate the expression of NK cell activating ligands on tumor cells (i.e. multiple myeloma, renal cell carcinoma), mainly in response to several chemotherapeutic agents. These studies highlighted the critical contribution of the DNA-damage response and senescence pathways in up-regulating their expression on different types of cancer cells. Furthermore, the analysis of the senescent secretome has elucidated some of the mechanisms capable of improving NK cell-tumor immune surveillance.

In the more recent past my interest is being addressed in studying the innate immune surveillance against high-risk human papillomavirus infection through the characterization of novel immunotherapeutic approaches to restore the intrinsic innate immune response, including IFN production (PRIN 2017, Prot. 20178ALPCM). In these studies, I propose to fill the gap between in vitro and in vivo experimentation by employing a bio-printed 3D platform to recapitulate the HPV-infected stratified epithelium.

Keywords

Natural Killer (NK) cells
tumor immune surveillance
innate immune response
HPV infection

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma